ES489493A0 - Un procedimiento para la preparacion de derivados de urea - Google Patents

Un procedimiento para la preparacion de derivados de urea

Info

Publication number
ES489493A0
ES489493A0 ES489493A ES489493A ES489493A0 ES 489493 A0 ES489493 A0 ES 489493A0 ES 489493 A ES489493 A ES 489493A ES 489493 A ES489493 A ES 489493A ES 489493 A0 ES489493 A0 ES 489493A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
urea derivatives
urea
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES489493A
Other languages
English (en)
Other versions
ES8103737A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8103737A1 publication Critical patent/ES8103737A1/es
Publication of ES489493A0 publication Critical patent/ES489493A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES489493A 1979-03-14 1980-03-13 Un procedimiento para la preparacion de derivados de urea Granted ES489493A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH241579 1979-03-14
CH17180 1980-01-10

Publications (2)

Publication Number Publication Date
ES8103737A1 ES8103737A1 (es) 1981-03-16
ES489493A0 true ES489493A0 (es) 1981-03-16

Family

ID=25683737

Family Applications (1)

Application Number Title Priority Date Filing Date
ES489493A Granted ES489493A0 (es) 1979-03-14 1980-03-13 Un procedimiento para la preparacion de derivados de urea

Country Status (10)

Country Link
EP (1) EP0016371A1 (es)
AU (1) AU5628380A (es)
DK (1) DK108780A (es)
ES (1) ES489493A0 (es)
FI (1) FI800559A7 (es)
GR (1) GR66630B (es)
IL (1) IL59563A0 (es)
MC (1) MC1317A1 (es)
NO (1) NO800720L (es)
PT (1) PT70949B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Healthcare Llc .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
SI1580188T1 (sl) 2002-02-11 2012-02-29 Bayer Healthcare Llc Aril sečnine kot kinazni inhibitorji
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
DE602004007382T2 (de) 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
DK1663978T3 (da) 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
JP2007535565A (ja) 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448869A1 (de) * 1973-10-19 1975-09-04 Mcneilab Inc 4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel
US3983135A (en) * 1974-09-23 1976-09-28 Mcneil Laboratories, Incorporated 4-Oxo-2-imidazolidinylidene ureas
US4025517A (en) * 1975-06-23 1977-05-24 Mcneil Laboratories, Incorporated 4-Oxo-2-hexahydropyrimidinylidene ureas

Also Published As

Publication number Publication date
DK108780A (da) 1980-09-15
ES8103737A1 (es) 1981-03-16
NO800720L (no) 1980-09-15
PT70949A (en) 1980-04-01
MC1317A1 (fr) 1981-03-10
EP0016371A1 (de) 1980-10-01
PT70949B (en) 1981-06-24
IL59563A0 (en) 1980-06-30
GR66630B (es) 1981-04-03
FI800559A7 (fi) 1981-01-01
AU5628380A (en) 1980-09-18

Similar Documents

Publication Publication Date Title
ES505548A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano
AR222204A1 (es) Un procedimiento para la preparacion de derivados de i-bencilimidazol
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES495977A0 (es) Un procedimiento para la preparacion de derivados acidos penem-carboxilicos
ES501805A0 (es) Un procedimiento para la preparacion de derivados de la eta-nolamina
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES500384A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES530788A0 (es) Un procedimiento para la preparacion de derivados de urea
ES487668A0 (es) Procedimiento para la preparacion de nuevos derivados de urea
ES489470A0 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES496487A0 (es) Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles
ES505556A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES492573A0 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina
ES485929A0 (es) Un procedimiento para la preparacion de derivados de 5-triazina
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES491992A0 (es) Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano
ES505544A0 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
ES500381A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
ES499432A0 (es) Un procedimiento para la preparacion de nuevos derivados de hidantoina
AR222208A1 (es) Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina
ES490011A0 (es) Un procedimiento para la preparacion de derivados de 2-epi- fortimicina.
ES489540A0 (es) Un procedimiento para la preparacion de 4-hidroximetil-5-me-tilimidazol